Weekly Recap | BAYZF.US -6.84%, broker with buy ratingWeekly Review·Oct 3, 2026 at 08:33 AMBAYZF0.00%
Bayer obtains the opportunity for a Supreme Court hearing to challenge the Roundup herbicide cancer lawsuitWallstreetcn·Jan 16, 2026 at 08:43 PMBAYZF0.00%
Bayer: Asundexian achieved primary endpoints in Phase 3 clinical trialsWallstreetcn·Nov 23, 2025 at 03:53 PMBAYZF0.00%
In the third quarter, Bayer's adjusted EBITDA was €1.51 billion, while the market estimate was €1.29 billionWallstreetcn·Nov 12, 2025 at 06:33 AMBAYZF0.00%
On the second day of the China International Import Expo, Meituan Medicine signed contracts with seven multinational pharmaceutical companiesWallstreetcn·Nov 6, 2025 at 12:56 PMPFE-0.86%GILD-1.88%
Bayer reaches a settlement in the polychlorinated biphenyl (PCB) case involving schools in the Seattle area of the United StatesWallstreetcn·Aug 18, 2025 at 07:14 PMBAYZF0.00%
Morgan Stanley, BMW, and Bayer issued Chinese panda bonds, following Hungary's action to finance through panda bonds in JulyWallstreetcn·Aug 8, 2025 at 02:59 PMBMWYYBAYZF0.00%
Bayer's pharmaceutical subsidiary revenue for the second quarter met expectationsWallstreetcn·Aug 6, 2025 at 05:31 AMBAYZF0.00%
In the first quarter, Bayer's adjusted EBITDA exceeded expectationsWallstreetcn·May 13, 2025 at 05:31 AMBAYZF0.00%
